Scott & Selber Inc’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.94M | Sell |
5,873
-7
| -0.1% | -$3.36K | 0.62% | 41 |
|
|
2026
Q1 | $2.89M | Sell |
5,880
-15
| -0.3% | -$8.14K | 0.75% | 40 |
|
|
2025
Q4 | $3.42M | Sell |
5,895
-219
| -4% | -$124K | 0.86% | 33 |
|
|
2025
Q3 | $2.97M | Sell |
6,114
-95
| -2% | -$44.2K | 0.76% | 38 |
|
|
2025
Q2 | $2.52M | Buy |
6,209
+37
| +0.6% | +$15.5K | 0.7% | 42 |
|
|
2025
Q1 | $3.07M | Buy |
6,172
+5
| +0.1% | +$2.71K | 0.98% | 32 |
|
|
2024
Q4 | $3.21M | Sell |
6,167
-184
| -3% | -$101K | 0.97% | 32 |
|
|
2024
Q3 | $3.93M | Sell |
6,351
-25
| -0.4% | -$14.8K | 1.22% | 23 |
|
|
2024
Q2 | $3.53M | Buy |
6,376
+103
| +2% | +$59K | 1.12% | 26 |
|
|
2024
Q1 | $3.65M | Buy |
6,273
+9
| +0.1% | +$5.05K | 1.24% | 24 |
|
|
2023
Q4 | $3.33M | Sell |
6,264
-67
| -1% | -$32.4K | 1.25% | 25 |
|
|
2023
Q3 | $3.21M | Sell |
6,331
-15
| -0.2% | -$7.99K | 1.33% | 21 |
|
|
2023
Q2 | $3.31M | Sell |
6,346
-20
| -0.3% | -$10.8K | 1.29% | 20 |
|
|
2023
Q1 | $3.67M | Buy |
6,366
+17
| +0.3% | +$9.58K | 1.56% | 17 |
|
|
2022
Q4 | $3.5M | Buy |
6,349
+12
| +0.2% | +$6.36K | 1.57% | 17 |
|
|
2022
Q3 | $3.21M | Buy |
6,337
+27
| +0.4% | +$15.1K | 1.55% | 16 |
|
|
2022
Q2 | $3.43M | Sell |
6,310
-65
| -1% | -$35.8K | 1.56% | 17 |
|
|
2022
Q1 | $3.77M | Sell |
6,375
-1,390
| -18% | -$798K | 1.45% | 17 |
|
|
2021
Q4 | $5.18M | Sell |
7,765
-22
| -0.3% | -$13.7K | 1.84% | 11 |
|
|
2021
Q3 | $4.45M | Sell |
7,787
-241
| -3% | -$132K | 1.8% | 11 |
|
|
2021
Q2 | $4.05M | Sell |
8,028
-91
| -1% | -$42.9K | 1.55% | 12 |
|
|
2021
Q1 | $3.71M | Buy |
8,119
+49
| +0.6% | +$23.4K | 1.52% | 14 |
|
|
2020
Q4 | $3.76M | Sell |
8,070
-372
| -4% | -$174K | 1.61% | 12 |
|
|
2020
Q3 | $3.73M | Buy |
8,442
+36
| +0.4% | +$14.9K | 1.67% | 15 |
|
|
2020
Q2 | $3.05M | Sell |
8,406
-114
| -1% | -$38.2K | 1.51% | 20 |
|
|
2020
Q1 | $2.42M | Buy |
8,520
+62
| +0.7% | +$19.6K | 1.51% | 20 |
|
|
2019
Q4 | $2.75M | Sell |
8,458
-50
| -0.6% | -$15.2K | 1.3% | 34 |
|
|
2019
Q3 | $2.48M | Buy |
8,508
+1
| +0% | +$286 | 1.27% | 37 |
|
|
2019
Q2 | $2.5M | Buy |
8,507
+129
| +2% | +$35.5K | 1.26% | 35 |
|
|
2019
Q1 | $2.29M | Sell |
8,378
-28
| -0.3% | -$6.97K | 1.2% | 39 |
|
|
2018
Q4 | $1.88M | Sell |
8,406
-134
| -2% | -$31.4K | 1.15% | 42 |
|
|
2018
Q3 | $2.08M | Buy |
8,540
+5
| +0.1% | +$1.15K | 1.03% | 47 |
|
|
2018
Q2 | $1.77M | Buy |
8,535
+43
| +0.5% | +$9.13K | 0.95% | 48 |
|
|
2018
Q1 | $1.75M | Sell |
8,492
-72
| -0.8% | -$15.1K | 0.99% | 45 |
|
|
2017
Q4 | $1.63M | Buy |
8,564
+63
| +0.7% | +$12.1K | 0.87% | 52 |
|
|
2017
Q3 | $1.61M | Buy |
+8,501
| New | +$1.54M | 0.93% | 47 |
|
|
2016
Q4 | – | Sell |
-14,912
| Closed | -$2.37M | – | 76 |
|
|
2016
Q3 | $2.37M | Buy |
+14,912
| New | +$2.3M | 1.49% | 37 |
|
|
2014
Q4 | – | Sell |
-16,577
| Closed | -$2.02M | – | 69 |
|
|
2014
Q3 | $2.02M | Sell |
16,577
-10,609
| -39% | -$1.29M | 1.41% | 47 |
|
|
2014
Q2 | $3.21M | Sell |
27,186
-140
| -0.5% | -$16.5K | 2.13% | 9 |
|
|
2014
Q1 | $3.29M | Buy |
27,326
+61
| +0.2% | +$7.25K | 2.31% | 8 |
|
|
2013
Q4 | $3.04M | Buy |
27,265
+54
| +0.2% | +$5.37K | 2.22% | 8 |
|
|
2013
Q3 | $2.51M | Hold |
27,211
| – | – | 2.02% | 15 |
|
|
2013
Q2 | $2.3M | Buy |
+27,211
| New | +$2.27M | 2.02% | 14 |
|
Other funds holding TMO
Scott & Selber Inc's TMO Position: Q2 2026 in Review
Scott & Selber Inc reduced its Thermo Fisher Scientific (TMO) stake by 0.12% in Q2 2026, selling an estimated $3.36K and leaving 5,873 shares worth $2.94M. The position accounts for 0.62% of the portfolio, ranked #41.
Scott & Selber Inc first reported a position in TMO in Q2 2013 and has held it in 43 quarters since. The position peaked at $5.18M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Scott & Selber Inc held 5,873 shares of Thermo Fisher Scientific worth $2.94M as of Q2 2026.
- Scott & Selber Inc sold 7 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.36K.
- Thermo Fisher Scientific made up 0.62% of Scott & Selber Inc's portfolio in Q2 2026, its #41 holding.
- Scott & Selber Inc first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 43 quarters since.
- Scott & Selber Inc's Thermo Fisher Scientific position peaked at $5.18M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Scott & Selber Inc's 13F filing for Q2 2026, filed 8 Jul 2026.